Analytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methods

BACKGROUND: The established methods for detecting prostate cancer (CaP) are based on tests using PSA (blood), PCA3 (urine), and AMACR (tissue) as biomarkers in patient samples. The demonstration of ERG oncoprotein overexpression due to gene fusion in CaP has thus provided ERG as an additional biomar...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Transl Med
Main Authors: He, Jintang, Schepmoes, Athena A, Shi, Tujin, Wu, Chaochao, Fillmore, Thomas L, Gao, Yuqian, Smith, Richard D, Qian, Wei-Jun, Rodland, Karin D, Liu, Tao, Camp, David G, Rastogi, Anshu, Tan, Shyh-Han, Yan, Wusheng, Mohamed, Ahmed A, Huang, Wei, Banerjee, Sreedatta, Kagan, Jacob, Srivastava, Sudhir, McLeod, David G, Srivastava, Shiv, Petrovics, Gyorgy, Dobi, Albert, Srinivasan, Alagarsamy
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2015
נושאים:
Methodology
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4342100/
https://ncbi.nlm.nih.gov/pubmed/25889691
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-015-0418-z
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים